Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.4.3 is added to the record history, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 added and a prior site-wide notice about funding (v3.4.1) removed. These updates are administrative and do not affect the study record content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check79 days agoChange DetectedAdded a site-wide government funding notice and updated operating-status information (cc.nih.gov and opm.gov). The history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check86 days agoChange DetectedThe new version adds a 'Show glossary' option and a revision note dated 2025-10-20, with color-coded additions (green) and deletions (red) explained for the study record changes.SummaryDifference1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.